Inactive Instrument
Eidos Therapeutics, Inc. Stock
Stocks
EIDX
US28249H1041
Biotechnology & Medical Research
| 1 day | -4.85% |
| Manager | Title | Age | Since |
|---|---|---|---|
Neil Kumar
CEO | Chief Executive Officer | 47 | 01/03/2016 |
Jonathan Fox
PSD | President | 69 | 01/10/2016 |
Uma Sinha
CTO | Chief Tech/Sci/R&D Officer | 69 | 01/06/2016 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan A. Barr
BRD | Director/Board Member | - | 26/01/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 26/01/21 | Issuer sale | Director | 25,973 | 0.0668% | ||
| 26/01/21 | Issuer sale | Director | 25,973 | 0.0668% | ||
| 26/01/21 | Don | Chief Technology Officer | 366,525 | 0.9431% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.85% | -4.63% | - | - | 4.75B | |
| -3.42% | +4.90% | +61.15% | +87.70% | 55.98B | |
| -0.48% | -2.28% | +52.08% | +70.57% | 53.69B | |
| +1.56% | -5.20% | +5.21% | +429.47% | 23.29B | |
| +0.04% | -0.01% | -17.61% | -14.67% | 23.15B | |
| -5.95% | -2.58% | +30.67% | -9.47% | 20.58B | |
| -0.94% | +0.40% | +32.07% | -30.16% | 17.76B | |
| -4.55% | -1.95% | +192.65% | +349.58% | 16.09B | |
| -6.91% | -5.83% | +26.53% | +644.30% | 15.93B | |
| +0.04% | -1.46% | +24.08% | +190.13% | 14B | |
| Average | -2.56% | -0.43% | +45.20% | +190.83% | 26.72B | |
| Weighted average by Cap. | -2.15% | -0.88% | +45.72% | +150.46% |
Employees
-
Choose MarketScreener 
